Updated codes 0213T-0215T, paravertebral facet joint injections, to be covered without pre-authorization. New codes 0219T-0222T, placement of posterior intrafacet implant, are considered experimental/investigational and are not covered.
Added coverage criteria for small cell lung cancer and breast cancer.
BI523 New
Symdeko
08/01/19
Used to treat cystic fibrosis; specialty drug covered under pharmacy benefit.
For urgent questions about QualChoice Medical Coverage Policies, please fax a completed Predetermination Request Form for each patient to 844.501.2830.